{"id":"doi:10.1146/annurev-pathol-042020-042741","kind":"review","title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance","authors":["Sreya Bagchi","Robert T. Yuan","Edgar G. Engleman"],"author_count":3,"year":2020,"published":"2020-11-16","venue":"Annual Review of Pathology Mechanisms of Disease","cited_by":2188,"doi":"10.1146/annurev-pathol-042020-042741","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1146/annurev-pathol-042020-042741","archive_url":"https://space-kitty.com/papers/doi:10.1146/annurev-pathol-042020-042741","updated":null,"pmid":"33197221","pmcid":null,"openalex_id":"W3106005610","pdf_url":"https://www.annualreviews.org/doi/pdf/10.1146/annurev-pathol-042020-042741","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}